Owner Allergan, Inc.

Inventors Fernandez-Salas, Ester; Aoki, Kei Roger; Steward, Lance E.

Agent Davies Collison Cave

Pub. Number AU-B-2003282790

PCT Number PCT/US2003/0280

PCT Pub. Number WO2004/029576

Priority 10/261,161 27.09.02 US

Filing date 4 September 2003

Wipo publication date 19 April 2004

Acceptance publication date 2 July 2009

C07K 14/035 (2006.01) Peptides having more than 20 amino acids

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12Q 1/10 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Enterobacteria

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/52 (2006.01) Investigating or analysing materials by specific methods not covered by groups -

G01N 33/533 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with fluorescent label

G01N 33/554 (2006.01) Investigating or analysing materials by specific methods not covered by groups - the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids